Total Payments
$7,630
2024 Payments
$1,584
Companies
40
Transactions
513
Medicare Patients
13,930
Medicare Billing
$519,904
Payment Breakdown by Category
Food & Beverage$7,625 (99.9%)
Education$5.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,625 | 512 | 99.9% |
| Education | $5.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,311 | 67 | $0 (2024) |
| ABBVIE INC. | $826.36 | 76 | $0 (2024) |
| Lilly USA, LLC | $771.94 | 60 | $0 (2024) |
| Novo Nordisk Inc | $711.16 | 52 | $0 (2024) |
| Amgen Inc. | $512.47 | 35 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $381.10 | 25 | $0 (2024) |
| PFIZER INC. | $335.68 | 25 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $275.51 | 18 | $0 (2024) |
| Abbott Laboratories | $227.41 | 13 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $227.31 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,584 | 100 | AstraZeneca Pharmaceuticals LP ($361.81) |
| 2023 | $1,312 | 92 | ABBVIE INC. ($211.03) |
| 2022 | $947.16 | 66 | AstraZeneca Pharmaceuticals LP ($193.60) |
| 2021 | $1,187 | 82 | AbbVie Inc. ($273.26) |
| 2020 | $640.60 | 40 | Allergan, Inc. ($176.89) |
| 2019 | $510.49 | 38 | Amgen Inc. ($125.68) |
| 2018 | $711.51 | 42 | Novo Nordisk Inc ($163.02) |
| 2017 | $737.48 | 53 | AstraZeneca Pharmaceuticals LP ($202.83) |
All Payment Transactions
513 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/19/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: Genetic Disease | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Gastroenterology | ||||||
| 12/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $7.90 | General |
| Category: Bone Health | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: DIABETES | ||||||
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: VACCINE | ||||||
| 11/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.44 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Respiratory | ||||||
| 10/25/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: DIABETES | ||||||
| 10/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Inflammation | ||||||
| 09/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: DIABETES | ||||||
| 09/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/06/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: INFECTIOUS DISEASES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 3,250 | 5,242 | $473,371 | $137,513 |
| 2022 | 37 | 3,544 | 5,699 | $489,875 | $134,144 |
| 2021 | 39 | 3,501 | 5,554 | $461,523 | $140,278 |
| 2020 | 39 | 3,635 | 5,914 | $428,055 | $107,969 |
Total Patients
13,930
Total Services
22,409
Medicare Billing
$519,904
Procedure Codes
153
All Medicare Procedures & Services
153 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 276 | 458 | $111,770 | $34,007 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 244 | 543 | $95,025 | $32,021 | 33.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 213 | 213 | $46,860 | $26,156 | 55.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $5,525 | $4,804 | 87.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 272 | 524 | $10,611 | $4,402 | 41.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 57 | 57 | $4,290 | $4,100 | 95.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 247 | 295 | $26,550 | $3,870 | 14.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 68 | 73 | $7,300 | $3,630 | 49.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 255 | 405 | $35,640 | $3,357 | 9.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 71 | 90 | $22,250 | $2,611 | 11.7% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 258 | 408 | $15,708 | $2,587 | 16.5% |
| 80076 | Liver function blood test panel | Office | 2023 | 240 | 291 | $26,190 | $2,331 | 8.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 57 | 57 | $1,995 | $1,682 | 84.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 65 | 98 | $8,428 | $1,613 | 19.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 45 | 92 | $4,140 | $1,492 | 36.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 106 | 156 | $6,630 | $1,355 | 20.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 71 | 132 | $8,052 | $1,257 | 15.6% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 57 | 238 | $3,094 | $988.54 | 32.0% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 238 | 304 | $8,512 | $945.43 | 11.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 40 | 40 | $3,160 | $756.80 | 23.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 21 | 21 | $945.00 | $619.71 | 65.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 20 | 20 | $1,580 | $360.40 | 22.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 31 | 32 | $3,360 | $331.20 | 9.9% |
| 86803 | Hepatitis c antibody measurement | Office | 2023 | 21 | 21 | $1,218 | $293.58 | 24.1% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 47 | 49 | $2,795 | $277.34 | 9.9% |
About Dr. Herman Kile, MD
Dr. Herman Kile, MD is a Family Medicine healthcare provider based in Texarkana, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992775100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Herman Kile, MD has received a total of $7,630 in payments from pharmaceutical and medical device companies, with $1,584 received in 2024. These payments were reported across 513 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($7,625).
As a Medicare-enrolled provider, Kile has provided services to 13,930 Medicare beneficiaries, totaling 22,409 services with total Medicare billing of $519,904. Data is available for 4 years (2020–2023), covering 153 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Texarkana, TX
- Active Since 01/23/2006
- Last Updated 04/08/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1992775100
Products in Payments
- FARXIGA (Drug) $808.68
- UBRELVY (Drug) $415.91
- VRAYLAR (Drug) $374.76
- XARELTO (Drug) $344.92
- BREZTRI (Drug) $342.83
- Ozempic (Drug) $303.71
- JARDIANCE (Drug) $293.88
- XIFAXAN (Drug) $281.93
- TRULICITY (Drug) $250.19
- FREESTYLE LIBRE 3 (Device) $212.91
- Otezla (Drug) $199.90
- Aimovig (Biological) $190.34
- QULIPTA (Drug) $170.55
- MOUNJARO (Drug) $165.92
- ELIQUIS (Drug) $165.66
- EMGALITY (Drug) $163.96
- Wegovy (Drug) $163.02
- Xofluza (Drug) $153.61
- Kerendia (Drug) $143.51
- LEQVIO (Drug) $130.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Texarkana
Gregory Richter, Md, MD
Family Medicine — Payments: $11,589
Family Medicine $11,589
Dr. Claudia Jordan, M.d, M.D
Family Medicine — Payments: $9,473
Family Medicine $9,473
Paul Gardial, M.d, M.D
Family Medicine — Payments: $8,603
Family Medicine $8,603
Dr. Blane Graves, Md, MD
Family Medicine — Payments: $8,027
Family Medicine $8,027
Mr. James Sarrett, Md, MD
Family Medicine — Payments: $7,382
Family Medicine $7,382
Kevin O'sullivan, M.d, M.D
Family Medicine — Payments: $6,155
Family Medicine $6,155